Corine Bertolotto
Team1, Equipe Labellisée Ligue 2020 And Equipe Labellisée ARC 2019
Nice, France
Nice, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 78 publications
Systematic identification of lincRNA-derived immunogenic peptides in melanoma.
Journal: Oncoimmunology
Published: August 02, 2025
SETDB1 is critically required for uveal melanoma growth and represents a promising therapeutic target.
Journal: Cell death & disease
Published: April 28, 2025
Publisher Correction: LKB1-SIK2 loss drives uveal melanoma proliferation and hypersensitivity to SLC8A1 and ROS inhibition.
Journal: EMBO molecular medicine
Published: August 20, 2024
Meeting Report From the 2023 Cure Ocular Melanoma (CURE OM) Global Science Meeting, Philadelphia, PA, November 2023.
Journal: Pigment cell & melanoma research
Published: June 19, 2024
AMBRA1 levels predict resistance to MAPK inhibitors in melanoma.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: June 13, 2024
Impact of COVID-19 on uveal melanoma in France.
Journal: Journal francais d'ophtalmologie
Published: May 12, 2024
Loss of LYN Is Frequent in Targeted Therapy-Resistant Melanoma Cells and Favors Metastatic Properties.
Journal: The Journal of investigative dermatology
Published: April 01, 2024
Messing with cancer therapy: how the melanoma phenotype predicts checkpoint inhibitor response.
Journal: Signal transduction and targeted therapy
Published: February 15, 2024
Assessment of Different Circulating Tumor Cell Platforms for Uveal Melanoma: Potential Impact for Future Routine Clinical Practice.
Journal: International journal of molecular sciences
Published: June 02, 2023
LKB1-SIK2 loss drives uveal melanoma proliferation and hypersensitivity to SLC8A1 and ROS inhibition.
Journal: EMBO molecular medicine
Published: March 17, 2023
Last Updated: 09/26/2026